“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation
A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation
Reviews
There are no reviews yet.
Be the first to review “Article: A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation” Cancel reply
Reviews
There are no reviews yet.